Clinical Trial Update: Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the safety and efficacy of low-dose ticagrelor in Chinese patients with stable coronary artery disease. The document provides …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN